Today19 events
To consider and approve the raising of funds through issuance of units.
To consider and approve the audited financial results for the year ended 31st March, 2026 and to recommend dividend if any, for the financial year 2025-26.
To consider and approve the Preferential Issue of Equity shares.
To consider and approve the revision in the consolidated financial statements of the Company. This revision is due to a clerical error identified in the financial statements of a subsidiary.
To consider and adopt audited financial statements and take on record the audit report for the quarter and year ended March 31, 2026.
To consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026.
To consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
To consider and approve audited standalone and consolidated financial results for the quarter and year ending March 31, 2026. Also, to consider the recommendation of a final dividend, if any, for the financial year ending March 31, 2026.
To decide regarding the conduct of an Extraordinary General Meeting for regularization of an Additional Director. Also, to consider appointing a scrutinizer for the EGM.
To consider and approve standalone and consolidated audited financial statements and financial results for the quarter and year ended March 31, 2026.
To consider and approve a proposal for the buyback of equity shares of the Company.
Board meeting scheduled to consider and approve the un-audited financial results (standalone and consolidated) of the company for the quarter and nine months ended December 31, 2025.
To consider and approve audited standalone and consolidated financial results for the quarter and year ending March 31, 2026, and to recommend dividend.
The Board will consider and approve the continuation/renewal of Loan extended to its Subsidiaries and the proposal for shifting the Registered office of the Company.
To consider and approve standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026.
To consider and approve the audited financial results for the quarter and year ended March 31, 2026.
To consider and approve the condensed audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
To consider and approve a proposal for fundraising by way of preferential issue/private placement of securities. Also, to consider and approve the appointment of Mr.
Tomorrow19 events
Mon, 20 Apr9 events
To consider and approve the proposal for migration of listing/trading of equity shares from BSE SME platform to Main Board of Bombay Stock Exchange and National Stock Exchange of India Limited.
To consider, approve and take on record the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026.
Tue, 21 Apr8 events
To consider and approve the audited financial results for the quarter and year ended 31 March 2026.
The Board will consider and approve the appointment of an Additional Director and amendments to the Memorandum of Association for business diversification. It will also approve the Notice of Postal Ballot, fix the cut-off date, and appoint a scrutinizer for the postal ballot process.
To consider and approve the audited financial results (standalone and consolidated) for the financial year ended March 31, 2026, and to approve the notice for the 20th Annual General Meeting.
To consider and approve the appointment of Company Secretary, including terms and remuneration.
To consider and approve audited financial results and statements for the quarter and year ended March 31, 2026, and to declare distributions to unitholders.
To consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026.
To consider and approve the Audited Standalone Financial Results for the quarter and Financial Year ended March 31, 2026. Also, to recommend a final dividend.
To consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026.
To consider and approve the standalone and consolidated audited financial results for the quarter and year ended March 31, 2026. Also, to recommend dividend on equity shares for the financial year ended March 31, 2026.
To consider and approve audited financial results and statements, and to declare distributions to unitholders for the quarter and year ended March 31, 2026.
To consider and approve a proposal to raise funds through issuance of equity shares and/or other permissible securities, including by way of a rights issue.
To consider and approve raising of funds through issuance of various securities and to consider increasing the Company's borrowing limits.
To consider and approve the Audited Standalone and Consolidated Financial Results of the Bank for the Quarter (Q4) and Year ended March 31, 2026.
To consider and approve Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026.
To consider and approve Standalone and Consolidated audited Financial Results of the company for the period ended on March 31, 2026.
To consider fund raising by way of issuance of debt securities and buyback of debt securities.
To consider and approve financial results and statements for the quarter and financial year ended March 31, 2026. Also, to consider and approve raising of funds via debt instruments and qualified institutions placement, and convening the 33rd Annual General Meeting.
To consider and approve audited financial results for the quarter and financial year ended on 31st March 2026. Also, to raise funds through preferential issue of shares/warrants and alter various clauses of the Memorandum of Association.
To consider and approve audited financial results for the financial year ended March 31, 2025, and to approve the date and time for the adjourned 56th Annual General Meeting.
To consider, approve and take on record the Audited Financial Results for the 4th quarter and Financial year ended 31st March, 2026. The board may also consider and recommend Final Dividend for FY 2025-26.
To consider and approve the declaration of 2nd Interim Dividend for the financial year 2025-26.
To consider and approve the audited standalone and consolidated financial results and recommend dividend for the financial year ended March 31, 2026.
To consider and approve the Audited Financial Results for the fourth quarter and year ended 31st March, 2026.
To consider and approve audited financial results for the financial year ended March 31, 2026, and to recommend dividend.
To consider and approve the annual audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. Also, to consider and recommend final dividend and discuss matters relating to the ensuing Annual General Meeting.
To consider and approve audited financial results for the quarter and year ended March 31, 2026. The Board may also consider recommendation of final dividend.
To consider increasing the authorized share capital and approve a material related party transaction for revision in project cost.
To consider and approve the audited financial results for the quarter and financial year ended 31 March 2026.
To consider and approve financial results for the quarter and year ended March 31, 2026, declare distributions to unitholders, and raise debt.
To consider and approve Audited Financial Results for the 4th quarter and financial year ended March 31, 2026, and to consider and recommend Final Dividend, if any.
To consider and approve the Audited Financial Results for the Quarter and Financial Year ended March 31, 2026, and to consider recommending Dividend, if any.
To consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider the recommendation of dividend.
To consider and approve the unaudited (standalone & consolidated) financial results for the quarter and nine months ended 31st March, 2026.